Abstract: Provided herein are antibodies, and antigen-binding fragments thereof that specifically bind glucocorticoid-induced tumor necrosis factor receptor (GITR) and methods of using the same, including, e.g., methods of treatment using the same.

Abstract: A composition of substituted crotonamide pharmaceutical and a preparation method therefor. The pharmaceutical composition comprises 5-50 parts of (E)-N-(3-cyano-7-ethoxy-4-(3-ethynylphenylamino)quinolin-6-yl)-4-(dimethylamino)but-2-enamide maleate, 40-120 parts of a filler, 2-20 parts of a disintegrant, 0-6 parts of an adhesive, and 0.5-5 parts of a lubricant. The filler is selected from carbohydrates.

Abstract: Systems, apparatuses and methods may provide for technology that determines a power-off period associated with a non-volatile memory (NVM), sets a completion time of a write procedure corresponding to the NVM to a first value if the power-off period exceeds a threshold, and sets the completion time to a second value if the power-off period does not exceed the threshold, wherein the first value is greater than the second value.

Abstract: The present disclosure discloses a display panel, a display device, and a control method of the display device. The display panel includes sub-pixels of a plurality of colors, wherein the sub-pixels of the plurality of colors include first blue sub-pixels and second blue sub-pixels, and a wavelength of each first blue sub-pixel is smaller than a wavelength of each second blue sub-pixel. The first blue sub-pixels and the second blue sub-pixels are driven to perform image display when the display panel is in a regular display mode; and the second blue sub-pixels are driven to perform image display when the display panel is in an eye protection display mode.

Abstract: Provided herein are antibodies, and antigen-binding fragments thereof that specifically bind glucocorticoid-induced tumor necrosis factor receptor (GITR) and methods of using the same, including, e.g., methods of treatment using the same.

Abstract: Disclosed are a light-emitting device, a display panel, and a driving method of the light-emitting device. The light-emitting device includes: a base substrate, a first electrode on a side of the base substrate, a second electrode on a side, facing away from the base substrate, of the first electrode, and at least two blue light-emitting layers located between the first electrode and the second electrode. Different blue light-emitting layers emit light with different wavelengths. The first electrode and the second electrode are configured to be applied with different voltages. A voltage difference between the first electrode and the second electrode includes a first threshold voltage and a second threshold voltage, and under control of the first threshold voltage, one of the blue light-emitting layers emits light; and under control of the second threshold voltage, another blue light-emitting layer emits light.

Abstract: An electroluminescent device, a method for manufacturing the electroluminescent device, a display panel and a display device are provided in the embodiments of the present application. The electroluminescent device includes an anode layer, a first hole injection layer and a hole transport layer. The first hole injection layer is located between the anode layer and the hole transport layer; the first hole injection layer includes at least two secondary hole injection layers, and an equivalent resistance value of the at least two secondary hole injection layers is greater than a first threshold value.

Abstract: Disclosed herein are methods and systems that can reconstruct, extract, and/or analyze TCR sequences using short reads. The methods and systems can be applied to both single cell and bulk sequencing data.

Abstract: We describe an antibody or antigen-binding fragment thereof comprising a heavy chain variable region (VH) sequence and a light chain variable region (VL) sequence of a clone selected from: 5C4, 4H1, 1D2, 1C4, 2B5, 1F1, 1H1, 4A5, 1D8, 1D3, 2F1, 3C6, 3D12, 3A9, 1F4, 1H10, 3C12, 4G11, 4A12, 1A12, 3G12, 4F9, 4G4 and 1E1 which is capable of specifically binding to glypican-3 (GPC-3) (GenBank Accession Number: NP_004475.1), or a sequence having at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% sequence identity thereto.

Abstract: A feed for enhancing immunity of tilapia and preparation method thereof, wherein the feed includes 20-30 parts of rice chaff, 15-25 parts of earthworm powder, 10-15 parts of shrimp shell powder, 10-15 parts of sodium alginate, 5-10 parts of oyster shell powder, 5-10 parts of cyclohexanone, 10-15 parts of honeysuckle extract, 3-5 parts of Commelina communis extract, 3-6 parts of ?-1,3-glucan, 2-3 parts of flavomycin growth promoter, 1-3 parts of complex enzyme preparation, 5-8 parts of selenium methionine, 6-10 parts of distiller's grains, 1-3 parts of complex vitamins, 1-3 parts of complex trace elements and 2-3 parts of food attractant, in parts by weight.

Abstract: A torsion spring used in a flexible display device includes a spring body having a first connection end configured to connect a reel of the flexible display device, and a second connection end configured to fix the torsion spring. An axial sectional area of the spring body near the first connection end is greater than an axial sectional area of the spring body away from the first connection end. When the reel rotates, the torsion force generated during the initial rotation of the reel is relatively large, and with the increase of the rotation turn number of the reel, the increase of the torsion force is relatively small.

Abstract: The present invention discloses a method for judgment of cheddar cheese grade based on identification characteristic flavor compounds, comprising the following steps: selecting cheddar cheese of different grades as standard product, and extracting volatile flavor compounds from the standard product; using gas phase-sniffing device to screen out characteristic flavor compounds with higher flavor intensity from the volatile flavor compounds through aroma extract dilution analysis; proceeding with clustering of characteristic flavor compounds as screened out to obtain identification characteristic flavor compounds of cheddar cheese; measuring the concentration of identification characteristic flavor composition of cheddar cheese of known grade, and establish the training set for training of support vector machine; measuring the concentration of identification characteristic flavor composition of cheddar cheese to be tested, and inputting it into the support vector machine trained to judge the grade of cheddar ch

Abstract: A display panel and an electronic device are provided. The display panel includes: an opening area; a display area surrounding the opening area; at least one isolation ring, wherein at least a part of the at least one isolation ring is located between the display area and the opening area, and the at least one isolation ring surrounds the opening area; and a drainage structure extending from a sidewall of an isolation ring in the at least one isolation ring along a straight line passing through a center of the isolation ring.

Abstract: Disclosed herein are methods and systems that can reconstruct, extract, and/or analyze TCR sequences using short reads. The methods and systems can be applied to both single cell and bulk sequencing data.

Abstract: An agricultural water-saving planning method based on a remotely-sensed ET includes the following steps: S1: determining an agricultural target ET of a crop; S2: establishing an agricultural water-saving planning model based on the agricultural target ET of the crop, and planning a planting area of the crop of a whole county to obtain a county-level planning scheme; and S3: decomposing the county-level planning scheme to township-level governments and further to village-level units for execution and supervision. The new method realizes the balance between real regional agricultural water consumption and actual water supply.

Abstract: Provided herein are antibodies, and antigen-binding fragments thereof that specifically bind glucocorticoid-induced tumor necrosis factor receptor (GITR), compositions comprising the antibodies or antigen-binding fragments thereof, and methods of using the same, including, e.g., methods of treatment using the same.

Abstract: The invention discloses a strain of Monascus purpureus with high esters producing activity and the application in the production of ester flavored Monascus cheese. The strain was deposited in China General Microbiological Culture Collection Center (CGMCC) on Oct. 17, 2019, with the preservation number of CGMCC 18589. The strain can make the cheese flavor having less pungent, and richer, significantly improve the odor quality of cheese, thus more in line with the taste of Chinese people. Moreover, some secondary metabolites responsible for health benefits including hypolipidemia, antihypertensive, antioxidant, and antihyperglycemic effects and prevention of obesity and diabetes development have been recognized in Monascus-fermented cheese.

Abstract: Provided herein are antibodies, and antigen-binding fragments thereof that specifically bind glucocorticoid-induced tumor necrosis factor receptor (GITR) and methods of using the same, including, e.g., methods of treatment using the same.

Abstract: Various embodiments support or provide for an extensible electronic claim verification system that offers extensible support for electronic verification by one or more external electronic claim verification services that are external to the extensible electronic claim verification system. For some embodiments, the extensible claim verification system is readily configurable (e.g., by a user) to add or remove access to one or more external claim verification services available for use through the extensible electronic claim verification system by a client device. Some embodiments implement the extensible support by using a unified protocol for interfacing with different external claim verification services. By use of the unified protocol, various embodiments enable an external claim verification service to plug into an extensible claim verification system, thereby permitting a user to extend support of the extensible claim verification system to different types of external claim verification services.

Abstract: Provided herein are antibodies, and antigen-binding fragments thereof that specifically bind glucocorticoid-induced tumor necrosis factor receptor (GITR) and methods of using the same, including, e.g., methods of treatment using the same.